Related Experiment Video
Updated: May 17, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Fas activates lipolysis in a Ca2+-CaMKII-dependent manner in 3T3-L1 adipocytes
Reto A Rapold1, Stephan Wueest, Adrian Knoepfel
1Division of Pediatric Endocrinology and Diabetology, University Children's Hospital, CH-8032 Zurich, Switzerland.
Abstract:
Fas (CD95) is a member of the tumor necrosis factor (TNF) receptor superfamily and plays a crucial role in the induction of apoptosis. However, like TNF, Fas can induce nonapoptotic signaling pathways. We previously demonstrated that mice lacking Fas specifically in adipocytes are partly protected from diet-induced insulin resistance, potentially via decreased delivery of FAs to the liver, as manifested by lower total liver ceramide content. In the present study, we aimed to delineate the signaling pathway involved in Fas-mediated adipocyte lipid mobilization. Treatment of differentiated 3T3-L1 adipocytes with membrane-bound Fas ligand (FasL) significantly increased lipolysis after 12 h without inducing apoptosis. In parallel, Fas activation increased phosphorylation of ERK1/2, and FasL-induced lipolysis was blunted in the presence of the ERK-inhibitor U0126 or in ERK1/2-depleted adipocytes. Furthermore, Fas activation increased phosphorylation of the Ca(2+)/calmodulin-dependent protein kinases II (CaMKII), and blocking of the CaMKII-pathway (either by the Ca(2+) chelator BAPTA or by the CaMKII inhibitor KN62) blunted FasL-induced ERK1/2 phosphorylation and glycerol release. In conclusion, we propose a novel role for CaMKII in promoting lipolysis in adipocytes.
Insights
Fas ligand activates Ca2+/calmodulin-dependent protein kinases II (CaMKII) in fat cells, promoting lipid breakdown (lipolysis) without causing cell death. This reveals a new pathway for regulating fat metabolism.
Area of Science:
- Cell Biology
- Metabolic Signaling
- Endocrinology
Background:
- Fas (CD95) is a TNF receptor superfamily member involved in apoptosis and non-apoptotic signaling.
- Previous studies linked adipocyte-specific Fas deficiency to protection from diet-induced insulin resistance.
- The precise signaling cascade for Fas-mediated adipocyte lipid mobilization remained unclear.
Purpose of the Study:
- To elucidate the signaling pathway mediating Fas-induced lipolysis in adipocytes.
- To identify key molecular players in Fas-activated lipid mobilization.
Main Methods:
- Treatment of differentiated 3T3-L1 adipocytes with membrane-bound Fas ligand (FasL).
- Assessment of lipolysis, apoptosis, and protein phosphorylation (ERK1/2, CaMKII).
- Use of specific inhibitors (U0126, KN62) and depletion techniques (siRNA) to block signaling pathways.
Main Results:
- FasL treatment increased adipocyte lipolysis without inducing apoptosis.
- Fas activation led to ERK1/2 phosphorylation, which was essential for lipolysis.
- FasL also increased CaMKII phosphorylation, and CaMKII inhibition blocked ERK1/2 phosphorylation and lipolysis.
Conclusions:
- Fas activation promotes adipocyte lipolysis via a pathway involving ERK1/2.
- Ca2+/calmodulin-dependent protein kinases II (CaMKII) acts upstream of ERK1/2 in this pathway.
- CaMKII plays a novel role in promoting lipolysis in adipocytes, independent of apoptosis.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Two...
Lipid Catabolism
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Fats as Energy Storage Molecules
Intracellular Signaling Affects Focal Adhesions
Some...

